Gasang, Rosemila D.
HRN: 22-57-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2025
CEFTRIAXONE 1G (VIAL)
03/05/2025
03/11/2025
IV
2g
OD
CAP MR, Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes